opinion
burzynski
antineoplaston
inform
current
statu
research
would
appreci
burzynski
work
promis
none
a1
a5
antineoplaston
shown
antineoplast
effect
experiment
cancer
nci
conduct
test
a2
a5
leukemia
mice
result
dose
high
enough
produc
toxic
effect
mice
effect
inhibit
growth
tumor
kill
1983
1985
burzynski
claim
a10
activ
factor
common
a1
a5
someth
shown
a10
extract
a2
also
hasnt
shown
a1
a5
actual
distinct
substanc
nci
conduct
seri
test
use
a10
standard
panel
tumor
includ
differ
cell
line
tumor
follow
class
leukemia
nonsmallcel
smallcel
lung
cancer
colon
cancer
cancer
central
nervou
system
melanoma
ovarian
cancer
renal
cancer
a10
exhibit
neither
growth
inhibit
cytotox
dose
level
test
necessari
process
a10
sinc
solubl
burzynski
theori
requir
solubl
agent
basic
hydrol
pag
call
25
pag
inform
carri
peptid
someth
byrzynski
claim
necessari
antineoplast
activ
21
also
deriv
a10
41
mixtur
pa
pag
pa
also
peptid
purchas
chemic
suppli
hous
009
gram
a10
chemic
extrem
similar
glutithamid
thalidomid
habit
form
caus
peripher
neuropathi
nasti
effect
thalidomid
wide
known
spite
similar
a10
appear
test
potenti
induc
teratogen
peripher
neuropathi
mani
burzynski
statement
origin
theori
earli
research
past
present
support
other
work
shown
untru
sdb
sdbssrcom
